Skip to main content
. 2016 Nov 4;7(51):84999–85020. doi: 10.18632/oncotarget.13113

Table 1. Summary of the main mutations in the PI3K-Akt pathway and p53, up to now reported in cell lines used in this study (Cosmic v75, http://cancer.sanger.ac.uk/cosmic).

Cell line PI3KCI PTEN Akt P53
OAW42 H1047L WT WT WT
OVCAR 3 WT WT ? WT R248Q
A2780 E365K K128_R130del WT WT
SKOV-3 H1047R WT WT Null